TM4SF19-DYNLT2B: A Drug Target / Disease Biomarker (G100534611)

Target Name: TM4SF19-DYNLT2B

NCBI ID: G100534611

TM4SF19-DYNLT2B

Other Name(s): TM4SF19-TCTEX1D2 | TM4SF19-DYNLT2B readthrough (NMD candidate)

TM4SF19-DYNLT2B: A Drug Target / Disease Biomarker

TM4SF19-DYNLT2B is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the superfamily of Transient Membrane Proteins (TMPs), which are a group of proteins that are characterized by the presence of a transmembrane region and a cytoplasmic tail. TMPs play a crucial role in various physiological processes, including signaling, intracellular signaling, and tissue structure and function.

TM4SF19-DYNLT2B is a 19 kDa protein that consists of 218 amino acid residues. It has a molecular weight of 21.1 kDa and a calculated pI of 11.95. TM4SF19-DYNLT2B is predominantly expressed in the brain, with a low expression in the pancreas and gastrointestinal tract. It is also expressed in other tissues, including muscle, heart, liver, and kidney.

The function of TM4SF19-DYNLT2B is not well understood, but it is thought to play a role in intracellular signaling. TM4SF19-DYNLT2B is involved in the regulation of various cellular processes, including cell adhesion, migration, and survival. It is also involved in the regulation of inflammation and immune responses.

TM4SF19-DYNLT2B is a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Its function as a protein that is involved in intracellular signaling makes it an attractive target for small molecules that can modulate its activity.

One of the potential mechanisms by which TM4SF19-DYNLT2B can be targeted by small molecules is through its role in intracellular signaling. TM4SF19-DYNLT2B is involved in the regulation of various cellular processes, including cell adhesion, migration, and survival. It is thought to play a role in the regulation of the Wnt signaling pathway, a pathway that is involved in the regulation of cell growth, differentiation, and survival.

Wnt signaling is a complex process that is involved in the regulation of many cellular processes, including cell adhesion, migration, and survival. It is thought to play a crucial role in the development and maintenance of tissues, including the nervous system and the cardiovascular system.

TM4SF19-DYNLT2B is involved in the regulation of the Wnt signaling pathway in various ways. First, it is thought to act as a negative regulator of the Wnt signaling pathway. This means that it works to reduce the activity of the Wnt signaling pathway, which is involved in the regulation of cell growth, differentiation, and survival.

Second, TM4SF19-DYNLT2B is involved in the regulation of the Wnt signaling pathway in terms of its levels. This means that it is involved in the regulation of the amount of Wnt protein that is present in the cell.

Third, TM4SF19-DYNLT2B is involved in the regulation of the Wnt signaling pathway in terms of its interactions with other proteins. This means that it is involved in the regulation of the interactions between the Wnt signaling pathway and other proteins.

TM4SF19-DYNLT2B is also involved in the regulation of the Notch signaling pathway, which is a signaling pathway that is involved in the regulation of cell growth, differentiation, and survival. It is thought to act as a positive regulator of the Notch signaling pathway, which means that it works to increase the activity of

Protein Name: TM4SF19-DYNLT2B Readthrough (NMD Candidate)

The "TM4SF19-DYNLT2B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TM4SF19-DYNLT2B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets